Richard Montes is the Senior Director of CMC Statistics at Alnylam Pharmaceuticals, bringing over 25 years of experience in pharmaceutical drug development. A PhD graduate from Georgia Institute of Technology, his expertise spans RNAi, biosimilars, and biologics, with a focus on statistical strategies for process optimization and regulatory approval.
He played a key role in influencing the FDAs regulatory framework for demonstrating analytical similarity in biosimilars during his time at Hospira/Pfizer.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.